Spinal Astrocytic Activation Contributes to Mechanical Allodynia in a Rat Chemotherapy-Induced Neuropathic Pain Model

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ji, Xi Tuan ^a   Qian, Nian Song ^b   Zhang, Tao ^c   Li, Jin Mao ^d   Li, Xin Kui ^a   Wang, Peng ^d   Zhao, Dong Sheng ^a   Huang, Gang ^a   Zhang, Lei ^a   Fei, Zhou ^a   Jia, Dong ^d   Niu, Le ^a,e  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE; VINCRISTINE SULFATE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOLECULAR PATHOLOGY; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPINAL ASTROCYTE; SPINAL CORD DORSAL HORN;

2-AMINOADIPIC ACID; ANIMALS; ASTROCYTES; GENE EXPRESSION; HYPERALGESIA; INJECTIONS, SPINAL; INTERLEUKIN-1BETA; MALE; MICROGLIA; MINOCYCLINE; NEURALGIA; PAIN MEASUREMENT; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SPINAL CORD; VINCRISTINE;

RATTUS;

EID: 84876050544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060733     Document Type: Article

References (61)

1. Cata JP, Weng HR, Lee BN, Reuben JM, Dougherty PM, (2006) Clinical and experimental findings in humans and animals with chemotherapy induced peripheral neuropathy. Minerva Anesthesiol 72: 151-169.
2. Kautio AL, Haanpää M, Kautiainen H, Kalso E, Saarto T, (2011) Burden of chemotherapy-induced neuropathy-a cross-sectional study. Support Care Cancer 19: 1991-1996.
3. Farquhar-Smith P, (2011) Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care 5: 1-7.
4. Topp KS, Tanner KD, Levine JD, (2000) Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristineinduced painful peripheral neuropathy in the rat. J Comp Neurol 424: 563-576.
5. Polomano RC, Mannes AJ, Clark US, Bennett GJ, (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94: 293-304.
6. Flatters SJL, Bennett GJ, (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. Pain 122: 245-257.
7. Tanner KD, Reichling DB, Gear RW, Paul SM, Levine JD, (2003) Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience 118: 809-817.
8. Weng HR, Cordella JV, Dougherty PM, (2003) Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103: 131-138.
9. Woolf CJ, Salter MW, (2000) Neuronal plasticity: increasing the gain in pain. Science 288: 1765-1769.
10. Brenner GJ, Ji RR, Shaffer S, Woolf CJ, (2004) Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur J Neurosci 20: 375-384.
11. Ultenius C, Linderoth B, Meyerson BA, Wallin J, (2006) Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 399: 85-90.
12. Watkins LR, Milligan ED, Maier SF, (2003) Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 521: 1-21.
13. Watkins LR, Maier SF, (2005) Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 257: 139-155.
14. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J, (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95: 15769-15774.
15. Tikka TM, Koistinaho JE, (2001) Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166: 7527-7533.
16. Mei XP, Xu H, Xie C, Ren J, Zhou Y, et al. (2011) Post-injury administration of minocycline: an effective treatment for nerve-injury induced neuropathic pain. Neurosci Res 70: 305-312.
17. Guasti L, Richardson D, JhaveriM, Eldeeb K, Barrett D, et al. (2009) Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol Pain 5: 35.
18. Padi SS, Kulkarni SK, (2008) Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol 601: 79-87.
19. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, et al. (2005) Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115: 71-83.
20. Raghavendra V, Tanga F, DeLeo JA, (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306: 624-630.
21. Khurgel M, Koo AC, Ivy GO, (1996) Selective ablation of astrocytes by intracerebral injections of alpha-aminoadipate. Glia 16: 351-358.
22. Wang W, Wang W, Mei X, Huang J, Wei Y, et al. (2009) Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain. PLoS One 4: e6973.
23. Feng QX, Wang W, Feng XY, Mei XP, Zhu C, et al. (2010) Astrocytic activation in thoracic spinal cord contributes to persistent pain in rat model of chronic pancreatitis. Neuroscience 167: 501-509.
24. Zheng FY, Xiao WH, Bennett GJ, (2011) The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience 176: 447-454.
25. Zhang H, Yoon SY, Zhang H, Dougherty PM, (2012) Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy. J Pain 13: 293-303.
26. Nozaki-Taguchi N, Chaplan SR, Higuera ES, Ajakwe RC, Yaksh TL, (2001) Vincristine-induced allodynia in the rat. Pain 93: 69-76.
27. Lynch 3rd JJ, Wade CL, Zhong CM, Mikusa JP, Honore P (2004) Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy induced neuropathic pain model. Pain 110: 56-63.
28. Pacharinsak C, Beitz A, (2008) Animal models of cancer pain. Comp Med 58: 220-233.
29. Zimmermann M, (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
30. Nadeson R, Tucker A, Bajunaki E, Goodchild CS, (2002) Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems. Br J Anaesth 88: 685-691.
31. Storkson RV, Kjorsvik A, Tjolsen A, Hole K, (1996) Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 65: 167-172.
32. Hua XY, Svensson CI, Matsui T, Fitzsimmons B, Yaksh TL, et al. (2005) Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci 22: 2431-2440.
33. Liu J, Feng X, Yu M, Xie W, Zhao X, et al. (2007) Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain. Neurosci Lett 412: 268-272.
34. Zhang RX, Li A, Liu B, Wang L, Ren K, et al. (2008) IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 135: 232-239.
35. Zanchet EM, Longo I, Cury Y, (2004) Involvement of spinal neurokinins, excitatory amino acids, proinflammatory cytokines, nitric oxide and prostanoids in pain facilitation induced by Phoneutria nigriventer spider venom. Brain Res 1021: 101-111.
36. Hao JX, Xu IS, Xu XJ, Wiesenfeld-Hallin Z, (1999) Effects of intrathecal morphine, clonidine and baclofen on allodynia after partial sciatic nerve injury in the rat. Acta Anaesthesiol Scand 43: 1027-1034.
37. Hargreaves K, Dubner R, Brown F, Flores C, Joris J, (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
38. Dumontet C, Sikic BI, (1999) Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol 17: 1061-1070.
39. Uhm JH, Yung WKA, (1999) Neurologic complications of cancer therapy. Curr Treat Options Neurol 1: 428-437.
40. Bosnjak S, Jelic S, Susnjar S, Luki V, (2002) Gabapentin for relief of neuropathic pain related to anticancer treatment: a preliminary study. J Chemother 14: 214-219.
41. Hempenstall K, Rice ASC, (2002) Current treatment options in neuropathic pain. Curr Opin Investig Drugs 3: 441-448.
42. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, et al. (2001) Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93: 247-257.
43. Dahl JL, (2002) Working with regulators to improve the standard of care in pain management: the U.S. experience. J Pain Symptom Manage 24: 136-147.
44. Fields RD, Stevens-Graham B, (2002) New insights into neuron-glia communication. Science 298: 556-562.
45. Watkins LR, Milligan ED, Maier SF, (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24: 450-455.
46. Zhuang ZY, Gerner P, Woolf CJ, Ji RR, (2005) ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114: 149-159.
47. Kiguchi N, Maeda T, Kobayashi Y, Kishioka S, (2008) Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristineinduced mechanical allodynia in mice. Neurosci Lett 445: 140-143.
48. Sweitzer SM, Pahl JL, DeLeo JA, (2006) Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat. Neurosci Lett 400: 258-261.
49. Heppelmann B, Messlinger K, Neiss WF, Schmidt RF, (1994) Mitochondria in fine afferent nerve fibres of the knee joint in the cat: a quantitative electron-microscopical examination. Cell Tissue Res 275: 493-501.
50. Chang DT, Honick AS, Reynolds IJ, (2006) Mitochondrial trafficking to synapses in cultured primary cortical neurons. J Neurosci 26: 7035-7045.
51. Virmani A, Gaetani F, Binienda Z, (2005) Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine. Ann NY Acad Sci 21053: 183-191.
52. Gradinaru D, Minn AL, Artur Y, Minn A, Heydel JM, (2012) Effect of oxidative stress on UDP-glucuronosyltransferases in rat astrocytes. Toxicol Lett 213: 316-324.
53. Volterra A, Meldolesi J, (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6: 626-640.
54. DeLeo JA, Yezierski RP, (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90: 1-6.
55. Zhang RX, Liu B, Wang L, Ren K, Qiao JT, et al. (2005) Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118: 125-136.
56. Raghavendra V, Tanga FY, DeLeo JA, (2004) Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20: 467-473.
57. Christoph T, Schiene K, Englberger W, Parsons CG, Chizh BA, (2006) The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism. Neuropharmacology 51: 12-17.
58. Dayer JM, (2003) The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford) 42: ii3-i10.
59. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, et al. (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471-475.
60. Mei XP, Wang W, Wang W, Zhu C, Chen L, et al. (2010) Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. ketamine, astrocytic inhibitor and pain. Mol Pain 6: 50.
61. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, et al. (2007) Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 27: 6006-6018.